U.S., Feb. 3 -- ClinicalTrials.gov registry received information related to the study (NCT07381803) titled 'The Impact of Fexofenadine Hydrochloride on the Prognosis of Patients Post-Acute Myocardial Infarction' on Jan. 05.
Brief Summary: The goal of this study is o evaluate the prognostic effect of fexofenadine hydrochloride in patients with myocardial infarction
Study Start Date: Jan. 27, 2025
Study Type: INTERVENTIONAL
Condition:
Zhejiang University
Intervention:
DRUG: Fexofenadine 60 Mg Oral Tablet
Fexofenadine, 60mg BID oral
DRUG: Placebo
placebo
Recruitment Status: RECRUITING
Sponsor: Second Affiliated Hospital, School of Medicine, Zhejiang University
Published by HT Digital Content Services with permission from Health Da...